Briefing: Who's making money off Trump's war in Iran?
Strategic angle: A look into the financial interests behind the ongoing conflict and its implications.
Strategic angle: A look into the financial interests behind the ongoing conflict and its implications.
Strategic angle: A significant change in the eGFR algorithm led to increased kidney transplant opportunities for Black patients.
Strategic angle: Gary Woodland reveals his struggle with post-traumatic stress disorder following brain surgery.
Strategic angle: An international team of researchers has modified a probiotic yeast to enhance safety for vulnerable populations.
Strategic angle: Vertex reported that its drug, acquired for $4.9 billion, halved a key marker of IgA nephropathy in late-stage trials.
Strategic angle: Two individuals arrested for carrying explosives at a protest in New York City reportedly cited the Islamic State as their motivation.
Strategic angle: A groundbreaking approach using CRISPR technology shows promise in treating heart failure by enhancing mitochondrial function.
Strategic angle: Researchers discover new functions of the cereblon protein that could enhance cancer drug efficacy.
Strategic angle: Research reveals how SYFO2 protein facilitates self-fertilization in legumes, enhancing agricultural efficiency.
Strategic angle: Want to make real money just by clicking on virtual trees? Starting today, residents of the United States can begin an online hunt for golden apples.
Strategic angle: A battle between doctors and a hospital system is an early test of a new law designed to separate business and medicine.
Strategic angle: Wall Street's verdict on Prasad, generic semaglutide's new pricing, and other biotech news
Strategic angle: Prasad out again, generic Ozempic on its way, and more health news from Morning Rounds
Strategic angle: Universal Health Services announces acquisition of virtual mental health company Talkspace.
Strategic angle: How a remote patient monitoring company is reworking its tech to enroll in a Medicare program seeking to align payment with health care outcomes.
The launch of ChatGPT Health by OpenAI prompts a critical examination of the risks associated with AI-driven health consultations.
Strategic implications in focus: Following OpenAI's recent ChatGPT Health launch, here are key points to consider before relying on AI chatbots for medical guidance.
A study in Health Affairs indicates that the new risk-adjustment model from CMS has not substantially altered Medicare Advantage benefits for the 2024-25 period.
Strategic implications in focus: An overview of critical issues in health care as discussed in Health Affairs.
Strategic implications in focus: Health Affairs, Volume 45, Issue 3, Page 238-245, March 2026.